Skip Navigation



American Journal of Epidemiology Advance Access published online on October 23, 2009

American Journal of Epidemiology, doi:10.1093/aje/kwp281
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Web Tables
Right arrow All Versions of this Article:
170/11/1396    most recent
kwp281v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schieve, L. A.
Right arrow Articles by Warner, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schieve, L. A.
Right arrow Articles by Warner, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2009.

Original Contribution

Estimation of the Contribution of Non–Assisted Reproductive Technology Ovulation Stimulation Fertility Treatments to US Singleton and Multiple Births

Laura A. Schieve*, Owen Devine, Coleen A. Boyle, Joann R. Petrini and Lee Warner

* Correspondence to Dr. Laura A. Schieve, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, MS E-86, 1600 Clifton Road, Atlanta, GA 30333 (e-mail: lschieve{at}cdc.gov).

Received for publication April 29, 2009. Accepted for publication August 10, 2009.

Infertility treatments that include ovulation stimulation, both assisted reproductive technologies (ARTs) and non-ART ovulation stimulation, are associated with increased risks of multiple birth and concomitant sequelae and adverse outcomes, even among singletons. While a US surveillance system for ART-induced births is ongoing, no population-based tracking system exists for births resulting from non-ART treatments. The authors developed a multistage model to estimate the uncertain proportion of US infants born in 2005 who were conceived by using non-ART ovulation treatments. Using published surveillance data, they estimated proportions of US multiple births conceived naturally and by ART and assumed that the remainder were conceived with non-ART treatments. They used Bayesian meta-analyses to summarize published clinical studies on the multiple-gestation risk associated with non-ART ovulation treatments, applied a fetal survival factor, and used this multiple-birth risk estimate and their own estimate of the proportion of US multiple births attributable to non-ART ovulation stimulation to estimate the total (and, through subtraction, singleton) proportion of infants conceived with such treatments. On the basis of the model, the authors estimate that 4.6% of US infants born in 2005 (95% uncertainty range: 2.8%–7.1%) resulted from non-ART ovulation treatments. Notably, this figure is 4 times greater than the ART contribution.

birth rate; infertility; meta-analysis; Monte Carlo method; ovulation induction

Abbreviations: ART, assisted reproductive technology; NASS, National ART Surveillance System; triplet/+, triplet or higher order


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.